Replies to post #904 on Bioxytran Inc (BIXT)

[RMacchio]

Interesting article. It was contributed by Chris Meeks... anyone know who that is?

Given the current dearth of simple/effective treatments for COVID, It's puzzling that BIXT isn't making more of a splash. Since Prolectin shows no toxicity or adverse side effects, you would think that countries like China and India would be fast-tracking approval of this drug.

I can see why the apparently corrupt FDA would slow walk any drug that would take market share from big Pharma but can't understand why countries with large at-risk populations and limited big Pharma influence wouldn't be knocking at BIXT's door.